Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-16CRDF3Initial Statement of Beneficial Ownership
This filing details the initial statement of beneficial ownership for Joshua B. Muntner, Chief Financial Officer of Cardiff Oncology, Inc. (CRDF). The report indicates that Mr. Muntner directly owns 500 shares of the company's Common Stock following a transaction. The ownership details are as of April 6, 2026, with the...
Micro CapBiotechnology
2026-04-16NVAX3Robert E. Walker Form 3 Filing and Power of Attorney for Novavax, Inc.
This SEC Form 3 filing reports the initial beneficial ownership of securities by Robert E. Walker, Executive Vice President of R&D at Novavax, Inc. The filing discloses Walker's holdings as of April 14, 2026, including 34,386 shares of common stock and multiple equity awards. The filing includes six derivative holdings...
Small CapBiotechnology
2026-04-16IMA3Form 3 Filing for ImageneBio, Inc. - Officer/Director Ownership
This filing is an initial statement of beneficial ownership of securities filed by Su Wei-guo, a director at ImageneBio, Inc. (IMA). The filing, dated April 16, 2026, indicates that the reporting owner has no securities owned. The reporting owner, Su Wei-guo, is identified with CIK 0002113925 and is associated with Ima...
Micro CapBiotechnology